Literature DB >> 9323279

Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology.

C D Inward1, A J Howie, M M Fitzpatrick, F Rafaat, D V Milford, C M Taylor.   

Abstract

Autopsy material was examined from British children dying early in the course of haemolytic uraemic syndrome (HUS). These presented after 1983, the period in which verocytotoxin-producing Escherichia coli (VTEC) infection was confirmed as the leading cause of diarrhoea-associated (D+HUS) in the United Kingdom. Of 18 cases referred for this study, 3 were found on review to have no history of a diarrhoeal prodrome (D-HUS). In the D+ patients, the median duration from onset of diarrhoea to death was 8 days (range 4-42 days). VTEC infection was confirmed in 6 cases. All had neutrophilia at presentation (median 21, range 15-49.8 x 10(9)/l). The 15 cases had uniform pathological features, consisting of glomerular thromboses and congested rather than ischaemic glomeruli. Arteriolar thromboses were common at the hilum of glomeruli and were sometimes also seen proximally, including in interlobular arteries. There were cortical infarcts in 5 cases with extensive thrombosis. Cases were demonstrated to have significantly greater numbers of neutrophils expressed per 100 glomeruli than controls, when counted using immunohistological stains to neutrophil elastase and CD15. This study showed uniformity of the renal changes in D+HUS and gave further evidence of the importance of neutrophils in the pathogenesis of the disease.

Entities:  

Mesh:

Year:  1997        PMID: 9323279     DOI: 10.1007/s004670050337

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  34 in total

1.  Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.

Authors:  Dakshina M Jandhyala; Trisha J Rogers; Anne Kane; Adrienne W Paton; James C Paton; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

2.  Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

Authors:  D Maroeska Te Loo; Leo Monnens; Thea van der Velden; Mohammed Karmali; Lambertus van den Heuvel; Victor van Hinsbergh
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  Two distinct cytotoxic activities of subtilase cytotoxin produced by shiga-toxigenic Escherichia coli.

Authors:  Naoko Morinaga; Kinnosuke Yahiro; Gen Matsuura; Masaharu Watanabe; Fumio Nomura; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Elisa Ravanelli; Antonio González Vara; Chiara Martinelli; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

5.  Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Authors:  Lisa M Harrison; Christel van den Hoogen; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

7.  Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Authors:  Ansgar Reising; Carsten Hafer; Marcus Hiss; Jan T Kielstein; Jan Menne; Faikah Gueler; Jan Beneke; Silvia Linnenweber-Held; Hermann Haller; Gunilla Einecke
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

Review 8.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

9.  Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.

Authors:  Anne-lie Ståhl; Lisa Sartz; Anders Nelsson; Zivile D Békássy; Diana Karpman
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

Review 10.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.